| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |